Back to Authors

Adrada, Beatriz E

0000-0002-5539-5332

Mayo Clinic

Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Tex.

Citations 2

Selection of Breast Biopsy Markers: Effect on Breast Imaging Procedures, Follow-up, and Costs
Moseley, Tanya W. , Adrada, Beatriz E. , Arribas, Elsa , Hesley, Gina , Whitman, Gary J. , Rauch, Ronald A., Guirguis, Mary S. , Kapoor, Megha , Lee, Christine U. , Hesley, Gina K. , Arribas, Elsa M , Urban, Matthew W , Whitman, Gary J , Rauch, Ronald A , Guirguis, Mary S , Kapoor, Megha M , Lee, Christine , Adrada, Beatriz E , Urban, Matthew W.

RadioGraphics | August 13, 2026 | Volume: 46 | Issue: 9 | Pages: No page available

10.1148/rg.250151 Get It

Breast biopsy markers have evolved from simple metallic devices to sophisticated multimaterial tools that have become essential for breast cancer care, demonstrating their clinical benefits in surgical planning, radiation targeting, and cost reduction.
Molecular Breast Imaging and Digital Breast Tomosynthesis for Dense Breast Screening: The Density MATTERS Trial
Hruska, Carrie B. , Hunt, Katie N. , Larson, Nicholas B. , Miller, Patricia A. , Ellis, Richard L. , Shermis, Robin B. , Rauch, Gaiane M. , Conners, Amy Lynn , Spilde, Jeannette Gasal, Semaan, D., Siegal, Emily C. , Zingula, Shannon N. , Mandava, Sabala, Martin, Tamara S., Ahmed, Riffat K., Whaley, Dana H. , Gray, Lacey R., Mehta, Ramila A. , Roll, Rebecca J, O’Connor, Michael K. , Rhodes, Deborah J. , Gasal Spilde, Jeannette, Mandava, Sabala R , Adrada, Beatriz E , Gray, Lacey R , Mehta, Ramila A , Roll, Rebecca J , Redfern, Roberta E , O'Connor, Michael K , Rhodes, Deborah J , Hruska, Carrie B , Larson, Nicholas B , Rauch, Gaiane M , Ahmed, Riffat K., Adrada, Beatriz E. , Redfern, Roberta E.

Radiology | September 23, 2025 | Volume: 316 | Issue: 3 | Pages: No page available

10.1148/radiol.243953 Get It

In women with dense breasts, adding molecular breast imaging to digital breast tomosynthesis (DBT) increased both overall and invasive cancer detection rates, while modestly raising the recall rate compared with DBT alone.